orlistat has been researched along with Cholestasis* in 1 studies
1 other study(ies) available for orlistat and Cholestasis
Article | Year |
---|---|
[A case of acute cholestatic hepatitis associated with Orlistat].
Orlistat(Xenical(R), Roche) is considered a safe and effective drug to treat obesity by reduced absorption of 30% digested fat. To date, no serious adverse effects affecting the liver have been published except a case of subacute hepatic failure leading to liver transplantation in a young women with moderate obesity treated with orlistat. We report a case of acute cholestatic hepatitis in a young woman with moderate obesity treated with orlistat: a 33-year-old female admitted for the evaluation of jaundice. Abdominal ultrasonography, ERCP, routine chemistry, viral markers, and a fine needle biopsy of liver were performed. Microscopic findings of the liver biopsy specimen were compatible with acute cholestatic hepatitis. After steroid therapy, liver function was improved. Topics: Acute Disease; Adult; Anti-Obesity Agents; Chemical and Drug Induced Liver Injury; Cholestasis; Female; Humans; Lactones; Lipase; Orlistat | 2002 |